Alphatec Holdings, Inc. (ATEC)Healthcare | Medical Devices | Carlsbad, United States | NasdaqGS
11.10 USD
+0.28
(2.588%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 11.08 -0.02 (-0.021%) ⇩ (April 17, 2026, 5:48 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:53 a.m. EDT
Alphatec is a fundamental 'destroy-to-create' play: the immediate outlook is terrible (negative earnings, revenue growth decelerating, negative operating margins) justifying avoidance for income, but the long-term valuation (roughly 2x sales, massive debt-to-equity, but a forward P/E of 19x on upcoming profitability) matches a classic early-stage biotech recovery narrative. The rocket-trading activity in OTM calls signals the market is betting on a name change or a monster recovery in the next 12 months. For a swing trader, this is a volatile shot in the dark; for a multi-year investor, it is a deep-value turnaround at a price that still implies 3-4x projected revenue by 2030. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.180022 |
| AutoARIMA | 0.189748 |
| AutoETS | 0.189751 |
| AutoTheta | 0.199178 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 9.56 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.313 |
| Excess Kurtosis | -1.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1654.478 |
| Revenue per Share | 5.092 |
| Market Cap | 1,680,058,624 |
| Forward P/E | 19.31 |
| Beta | 1.12 |
| Profit Margins | -18.76% |
| Website | https://www.atecspine.com |
As of April 19, 2026, 12:53 a.m. EDT: Speculators exhibit a distinct bullish bias in near-to-intermediate term positioning. The call side shows significant Open Interest (OI) on strikes $17.5 ($25k), $25.0 ($97k), and $22.5 ($475k) for expirations beyond 3-6 months, while put OI is heavily skewed deep in-the-monthly and deeply ITM for 2027+. The $12.5 strike holds the most OI on the immediate May expiration, suggesting a neutral-to-slight downside hedge, but the heavy heavy OTM call wall for 2027 indicates a 'momentum play' or 'catch-up trade' strategy where traders expect a significant rally (>70% appreciation to $25+) to pay off long-dated calls, implying high volatility or a fundamental turnaround story.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.043233037 |
| Address1 | 1,950 Camino Vida Roble |
| All Time High | 105.6 |
| All Time Low | 1.18 |
| Ask | 11.14 |
| Ask Size | 3 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 2,020,830 |
| Average Daily Volume3 Month | 2,595,340 |
| Average Volume | 2,595,340 |
| Average Volume10Days | 2,020,830 |
| Beta | 1.119 |
| Bid | 11.08 |
| Bid Size | 3 |
| Board Risk | 8 |
| Book Value | 0.083 |
| City | Carlsbad |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.1 |
| Current Ratio | 2.057 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 11.425 |
| Day Low | 10.975 |
| Debt To Equity | 1,654.478 |
| Display Name | Alphatec |
| Dividend Date | 1,472,083,200 |
| Earnings Call Timestamp End | 1,771,968,600 |
| Earnings Call Timestamp Start | 1,771,968,600 |
| Earnings Timestamp | 1,771,966,800 |
| Earnings Timestamp End | 1,777,579,200 |
| Earnings Timestamp Start | 1,777,579,200 |
| Ebitda | 19,526,000 |
| Ebitda Margins | 0.02555 |
| Enterprise To Ebitda | 109.544 |
| Enterprise To Revenue | 2.799 |
| Enterprise Value | 2,138,947,456 |
| Eps Current Year | 0.28706 |
| Eps Forward | 0.57482 |
| Eps Trailing Twelve Months | -0.96 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 800 431 9722 |
| Fifty Day Average | 12.4182 |
| Fifty Day Average Change | -1.3181992 |
| Fifty Day Average Change Percent | -0.10615058 |
| Fifty Two Week Change Percent | 4.3233037 |
| Fifty Two Week High | 23.29 |
| Fifty Two Week High Change | -12.190001 |
| Fifty Two Week High Change Percent | -0.5234006 |
| Fifty Two Week Low | 10.11 |
| Fifty Two Week Low Change | 0.9900007 |
| Fifty Two Week Low Change Percent | 0.09792292 |
| Fifty Two Week Range | 10.11 - 23.29 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,150,119,000,000 |
| Float Shares | 119,020,792 |
| Forward Eps | 0.57482 |
| Forward P E | 19.310394 |
| Free Cashflow | 56,146,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 913 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.69605005 |
| Gross Profits | 531,888,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.22179002 |
| Held Percent Institutions | 0.81531996 |
| Implied Shares Outstanding | 151,356,620 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://investors.alphatecspine.com/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,472,083,200 |
| Last Split Factor | 1:12 |
| Long Business Summary | Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California. |
| Long Name | Alphatec Holdings, Inc. |
| Market | us_market |
| Market Cap | 1,680,058,624 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_21766771 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -143,358,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,681,572,048 |
| Number Of Analyst Opinions | 12 |
| Open | 11.17 |
| Operating Cashflow | 45,231,000 |
| Operating Margins | -0.025179999 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.48 |
| Phone | 760 431 9286 |
| Post Market Change | -0.020600319 |
| Post Market Change Percent | -0.18558845 |
| Post Market Price | 11.0794 |
| Post Market Time | 1,776,462,488 |
| Previous Close | 10.82 |
| Price Eps Current Year | 38.667877 |
| Price Hint | 2 |
| Price To Book | 133.73495 |
| Price To Sales Trailing12 Months | 2.1985836 |
| Profit Margins | -0.1876 |
| Quick Ratio | 1.217 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.280001 |
| Regular Market Change Percent | 2.58781 |
| Regular Market Day High | 11.425 |
| Regular Market Day Low | 10.975 |
| Regular Market Day Range | 10.975 - 11.425 |
| Regular Market Open | 11.17 |
| Regular Market Previous Close | 10.82 |
| Regular Market Price | 11.1 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 2,558,268 |
| Return On Assets | -0.046240002 |
| Return On Equity | -6.30658 |
| Revenue Growth | 0.204 |
| Revenue Per Share | 5.092 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 151,356,620 |
| Shares Percent Shares Out | 0.0988 |
| Shares Short | 14,949,106 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 13,742,788 |
| Short Name | Alphatec Holdings, Inc. |
| Short Percent Of Float | 0.1192 |
| Short Ratio | 6.33 |
| Source Interval | 15 |
| State | CA |
| Symbol | ATEC |
| Target High Price | 28.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 24.25 |
| Target Median Price | 25.0 |
| Total Cash | 160,806,000 |
| Total Cash Per Share | 1.062 |
| Total Debt | 596,092,032 |
| Total Revenue | 764,155,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.96 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 15.432 |
| Two Hundred Day Average Change | -4.332 |
| Two Hundred Day Average Change Percent | -0.28071538 |
| Type Disp | Equity |
| Volume | 2,558,268 |
| Website | https://www.atecspine.com |
| Zip | 92,008 |